Gilead Sciences, Inc (GILD) with a beta value of 0.36 appears to be a promising investment opportunity.
Gilead Sciences, Inc (NASDAQ: GILD) on Tuesday, soared 1.08% from the previous trading day, before settling in for the closing price of $106.74. Within the